Results 151 to 160 of about 31,435 (210)

Comparative analysis of low-dose letrozole versus GnRH agonist on implantation markers and IVF outcomes in symptomatic adenomyosis: a randomized trial. [PDF]

Sci Rep
Sharma S, RoyChoudhury S, Chakraborty P, Paladhi P, Shaw K, Karan M, Hazra S, Hui SP, Chattopadhyay R, Majhi AK.   +9 more
europepmc   +1 more source

Comparing ovulation induction strategies for unexplained infertility: protocol for a systematic review and network meta-analysis. [PDF]

BMJ Open
Mehta P, Jajodia S, Sulochanadevi BC, Poornima M, Kalabharathi HL.   +4 more
europepmc   +1 more source

Case Report: Late choroidal metastasis from hormone receptor-positive, HER2-negative breast cancer responsive to first-line endocrine therapy. [PDF]

Front Oncol
Alsharif H, Wesolowski R, Cebulla CM, Davenport AP, Gatti-Mays ME, Johnson KCC, Lopetegui-Lia N, Quiroga D, Roy AM, Shujaat M, Stover DG, Bader G.   +11 more
europepmc   +1 more source

R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 24. [PDF]

J Comp Eff Res
Arora P, Ramagopalan SV.
europepmc   +1 more source

Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial. [PDF]

Nat Commun
Konstantinopoulos PA, Zhou N, Penson RT, Le TV, Campos S, Krasner C, Wright AA, Porter R, Horowitz N, Bouberhan S, Liu JF, Hindenach S, Sawyer H, Koppermann L, Hayes M, Polak M, Shea M, Widick P, Cheng SC, Castro C, Beumer JH, Matulonis UA, Lee EK.   +22 more
europepmc   +1 more source

Outcomes of Anastrozole, Letrozole, and Exemestane in Patients With Postmenopausal Breast Cancer. [PDF]

JAMA Netw Open
Dumas E, Hamy AS, Wanis KN, Jochum F, Coussy F, Giacchetti S, Gaillard T, Laas E, Houzard S, Le Bihan-Benjamin C, Reyal F, Gougis P, Stensrud MJ.   +12 more
europepmc   +1 more source

No evidence for genotype-treatment interactions with breast cancer endocrine therapy adverse effects in UK Biobank. [PDF]

NPJ Breast Cancer
Mokbel K, Weedon MN, Moye V, Ruth KS, Jackson L.   +4 more
europepmc   +1 more source

Efficiency of mild ovarian stimulation with letrozole co-treatment in expected low ovarian responders. [PDF]

JBRA Assist Reprod
Cortés-Vazquez A, Perez-Bautista I, Mejicanos-Quiñonez JA, Salazar-Ochoa HR, Peraza-Briones MC, Moreno-García JD, Cortés-Algara AL.   +6 more
europepmc   +1 more source

Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancer. [PDF]

Cell Rep Med
Cottu P, Kieffer Y, Lemonnier J, D'hondt V, Duhoux FP, Callens C, Gentien D, Reyes C, Boulai A, Desmoulins I, Mouret-Reynier MA, Levy C, Heudel PE, Dalenc F, Grenier J, Fuhrmann L, Baulande S, Delaloge S, Mechta-Grigoriou F, Vincent-Salomon A.   +19 more
europepmc   +1 more source

Considerations for emulations of randomized controlled trials using real-world data: learnings from an emulation of MONALEESA-2. [PDF]

J Comp Eff Res
Kong AM, Andrean D, Khan S, Choi J, Mamtani R, Parikh R, Jaksa A, Campbell U.   +7 more
europepmc   +1 more source